Wells David R. 4
4 · Envoy Medical, Inc. · Filed Oct 17, 2023
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-10-15+293,250→ 293,250 totalExercise: $2.40Exp: 2033-10-15→ Class A Common Stock (293,250 underlying)
Footnotes (1)
- [F1]Options to purchase 73,313 shares vest on 10/15/2024, and the remaining 219,937 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.